Sperm
8
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Sperm Selection by Rheotaxis and Thermotaxis in In-Situ Handmade Microfluidics of Fluidic Walls in the Same ICSI Plate
Impact of Telomere Biology and Sperm DNA Fragmentation on Embryonic Development
Ejaculation Frequency and Semen Parameters
To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS
Male Fertility and Sperm Cryopreservation
TNFSF11 Inhibition and Fertility: a Prospective Study
The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation
Effect of Dietary DHA Supplementation on Sperm Quality